LOSS OF HETEROZYGOSITY AT 17p13 IN GASTRIC CANCER AND COLORECTAL CANCER

被引:0
|
作者
李明发
单祥年
吴国俊
余龙
赵寿元
机构
关键词
Gastric cancer; Colorectal cancer; Loss of heterozygosity; p53;
D O I
暂无
中图分类号
R735.2 [胃肿瘤];
学科分类号
摘要
Southern hybridization was done on DNA samples of22 gastric tumors and corresponding normal tissues, 14colorectal tumors and corresponding normal tissues by probe phs53B mapping at 17P13.1 and probe PYNZ22mapping at 17pl3.3 which were purchased from the American Type Culture Collection. RFLP heterozygosity was observed in 12 normal tissues of gastric cancers and 10 normal tissues of colorectal cancers. Among these informative tumors, 6(50%) cases of gastric cancers and 6(60%) cases of colorectal cancers showed the loss of beterozygosity at 17p13. Our results demonstrated that the inactivation of wild type p53 might be involved in the carcinogenesis of gastric cancers and colorectal cancers.Furthermore, the mode of inactivation of p53 was in accord with the "two hits" hypothesis by Anudson. The signincance was discussed regarding the presence of LOH detected by probe PYNZ22 mapping at 17pl3.3.
引用
收藏
页码:24 / 27
页数:4
相关论文
共 50 条
  • [2] Loss of heterozygosity in colorectal cancer
    Ozaslan, Mehmet
    Aytekin, Turkan
    AFRICAN JOURNAL OF BIOTECHNOLOGY, 2009, 8 (25): : 7308 - 7312
  • [3] Allelic loss of chromosome 9p21 and 17p13 in metastatic progression of bladder cancer
    Cheng, L
    Bostwick, DG
    Li, G
    Vortmeyer, AO
    Zhuang, ZP
    LABORATORY INVESTIGATION, 2001, 81 (01) : 104A - 104A
  • [4] Loss of Heterozygosity (LOH) at 17p13 and 22q13 are Shared by Breast and Thyroid Carcinomas for Metastasis
    Lin, Xiaoqi
    Finkelstein, Sydney D.
    Silverman, Jan F.
    APPLIED IMMUNOHISTOCHEMISTRY & MOLECULAR MORPHOLOGY, 2019, 27 (02) : e16 - e19
  • [5] Allelic loss of chromosome 9p21 and 17p13 in metastatic progression of bladder cancer
    Cheng, L
    Bostwick, DG
    Li, G
    Vortmeyer, AO
    Zhuang, ZP
    MODERN PATHOLOGY, 2001, 14 (01) : 104A - 104A
  • [6] Association of p53 accumulation with TP53 mutations, loss of heterozygosity at 17p13, and DNA ploidy status in 273 colorectal carcinomas
    Clausen, OPF
    Lothe, RA
    Borresen-Dale, AL
    De Angelis, P
    Chen, Y
    Rognum, TO
    Meling, GI
    DIAGNOSTIC MOLECULAR PATHOLOGY, 1998, 7 (04) : 215 - 223
  • [7] Loss of Heterozygosity (LOH) at 17p13 and 22q13 Is Associated with Metastasis and Shared by Breast and Thyroid Carcinomas
    Zhu, B.
    Finkelstein, S. D.
    Silverman, J. F.
    Rohan, S. M.
    Liu, X.
    MODERN PATHOLOGY, 2013, 26 : 447A - 448A
  • [8] Loss of Heterozygosity (LOH) at 17p13 and 22q13 Is Associated with Metastasis and Shared by Breast and Thyroid Carcinomas
    Zhu, B.
    Finkelstein, S. D.
    Silverman, J. F.
    Rohan, S. M.
    Lin, X.
    LABORATORY INVESTIGATION, 2013, 93 : 447A - 448A
  • [9] Reduced expression and loss of heterozygosity of the SDHD gene in colorectal and gastric cancer
    Habano, W
    Sugai, T
    Nakamura, S
    Uesugi, N
    Higuchi, T
    Terashima, M
    Horiuchi, S
    ONCOLOGY REPORTS, 2003, 10 (05) : 1375 - 1380
  • [10] Targeting loss of heterozygosity in colorectal cancer
    Rameika, N.
    Zhang, X.
    Rendo, V.
    Kundu, S.
    Globisch, D.
    Correia, M.
    Stoimenov, I.
    Sjoblom, T.
    ANNALS OF ONCOLOGY, 2022, 33 : S303 - S303